Seravalle Gino, Grassi Guido
Cardiology Department, S. Luca Hospital, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Medical Clinic, S. Gerardo Hospital, University Milano-Bicocca, Monza, Italy.
Pharmacol Res. 2017 Aug;122:1-7. doi: 10.1016/j.phrs.2017.05.013. Epub 2017 May 19.
Obesity and in particular the excessive visceral fat distribution is accompanied by several alterations at hormonal, inflammatory and endothelial level. These alterations induce a stimulation of several other mechanisms that contribute to the hypertensive state and on the other side to increase the cardiovascular morbidity. In these chapter we will examine the main mechanisms of obesity and obesity-related hypertension and in particular the role of sympathetic nervous system, the alterations of the renal function and at the microvascular level. We will also depict the role of insulin resistance as factor stimulating and potentiating the other mechanisms. The second part will be focalized on the major target organ damage linked with obesity and obesity-related hypertension. We will finally describe the management and treatment of obesity and the antihypertensive drug therapies more effective in hypertensive obeses.
肥胖,尤其是内脏脂肪过度分布,会在激素、炎症和内皮水平上伴随多种改变。这些改变会引发其他多种机制的激活,这些机制一方面导致高血压状态,另一方面增加心血管疾病的发病率。在本章中,我们将研究肥胖及肥胖相关高血压的主要机制,尤其是交感神经系统的作用、肾功能的改变以及微血管水平的改变。我们还将阐述胰岛素抵抗作为刺激和增强其他机制的因素所起的作用。第二部分将聚焦于与肥胖及肥胖相关高血压相关的主要靶器官损害。我们最后将描述肥胖的管理和治疗方法,以及对肥胖型高血压患者更有效的抗高血压药物治疗。